Wasu Supharattanasitthi Selected Research

Wasu Supharattanasitthi Research Topics

4	Macular Degeneration (Age-Related Maculopathy) 01/2023 - 01/2019
2	Inflammation (Inflammations) 05/2023 - 12/2021
2	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2019
1	Hemorrhage 12/2021
1	Wounds and Injuries (Trauma) 12/2021
1	Hyperuricemia 10/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2021
1	Rupture 10/2021
1	Dyslipidemias (Dyslipidemia) 10/2021
1	Gout 10/2021
1	Blindness (Hysterical Blindness) 11/2020

2	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2020
2	Cystatin CIBA 01/2020 - 01/2019
1	Free RadicalsIBA 05/2023
1	Protein SIBA 01/2023
1	LigandsIBA 12/2021
1	Dasatinib (BMS 354825)FDA Link 12/2021
1	CollagenIBA 12/2021
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 12/2021
1	FibrinIBA 12/2021
1	Fibrinogen (Factor I)FDA Link 12/2021
1	platelet membrane glycoprotein VIIBA 12/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021
1	C-Type Lectins (C-Type Lectin)IBA 12/2021
1	LDL CholesterolIBA 10/2021
1	Hemoglobins (Hemoglobin)IBA 10/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021
1	CreatinineIBA 10/2021
1	LipidsIBA 10/2021
1	oxidized low density lipoproteinIBA 10/2021
1	Uric Acid (Urate)IBA 10/2021
1	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 10/2021
1	Retinaldehyde (Retinal)IBA 11/2020
1	Retinal Pigments (Pigments, Visual)IBA 01/2020
1	Cysteine Proteinase InhibitorsIBA 01/2020